Effects of methylprednisolone on femoral bone marrow: age-dependent susceptibility

Wing P Chan1, Tzong-Fu Kuo, Yun-Ho Lin

  • 11 Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University; Department of Radiology, Wan Fang Hospital, Taipei Medical University, Taipei - Taiwan.

Abstract

Insights

Methylprednisolone affects chicken bone marrow differently based on age, with younger birds showing more significant changes like new bone formation. Individual responses to this corticosteroid can also vary.

Area of Science:

  • Veterinary Medicine
  • Bone Biology
  • Pharmacology

Background:

  • Corticosteroids like methylprednisolone are widely used but can have significant side effects.
  • Bone marrow is a critical site for hematopoiesis and bone remodeling, and its response to drugs is of clinical interest.
  • Understanding the age-dependent effects of methylprednisolone on bone marrow is crucial for optimizing treatment and minimizing adverse outcomes in avian species.

Purpose of the Study:

  • To investigate the age-sensitivity of methylprednisolone's effects on chicken bone marrow.
  • To determine if prolonged methylprednisolone treatment exacerbates its impact on bone marrow.
  • To explore the potential for individual variability in the bone marrow response to methylprednisolone.

Main Methods:

  • Histological evaluation of bone marrow in control and methylprednisolone-treated chickens across different age groups (pubertal, young, adult).
  • Assessment of parameters including fat cell proliferation, trabecular bone loss, necrosis, and new bone formation in the femur.
  • Analysis of histological changes at various time points (12 to 50 weeks) post-treatment.

Main Results:

  • Significant differences in new bone formation and fat cell proliferation were observed in pubertal and young chickens treated with methylprednisolone compared to controls.
  • Adult chickens showed no significant differences in bone marrow parameters between control and treated groups.
  • Necrosis of bone and marrow occurred in both control and treated groups with no statistically significant difference.

Conclusions:

  • Younger chickens appear more susceptible to the bone marrow effects of methylprednisolone.
  • The study suggests that the femoral marrow's response to methylprednisolone can be variable among individual animals.
  • These findings highlight the importance of considering age and individual factors when administering methylprednisolone in chickens.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.1K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
378
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
868
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
406